BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2021 7:14:11 AM | Browse: 977 | Download: 2042
Publication Name World Journal of Gastroenterology
Manuscript ID 66136
Country Poland
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Evidence Review
Article Title Venous and arterial thromboembolism in patients with inflammatory bowel diseases
Manuscript Source Invited Manuscript
All Author List Antoni Stadnicki and Izabela Stadnicka
ORCID
Author(s) ORCID Number
Antoni Stadnicki http://orcid.org/0000-0003-2675-3732
Izabela Stadnicka http://orcid.org/0000-0003-3522-4058
Funding Agency and Grant Number
Corresponding Author Antoni Stadnicki, DSc, MD, PhD, Professor, Department of Physiology, Faculty of Medicine, University of Technology, Ul. Rolna, Katowice 41-209, Poland. astadnic@wp.pl
Key Words Inflammatory bowel disease; Thrombosis; Coagulation; Bacterial components; Prophylaxis; Post-thrombotic syndrome
Core Tip Patients with inflammatory bowel disease (IBD) are at a significantly higher risk for venous thromboembolism than patients with other inflammatory and immune-mediated diseases. The prevalence of arterial vascular disease is also higher in IBD. Inflammatory and molecular aspects of coagulation cascades are strictly linked and share several common mediators, including bacterial components as a possible link between intestinal microbiota and coagulation. We explored risk factors of thrombosis in IBD including clinical specificity, fibrin clot phenotype, Clostridium difficile infection, medications and surgery. We also presented long-lasting thromboembolic complications and considered the advantage of post-discharge venous thromboembolism prophylaxis.
Publish Date 2021-10-27 07:14
Citation Stadnicki A, Stadnicka I. Venous and arterial thromboembolism in patients with inflammatory bowel diseases. World J Gastroenterol 2021; 27(40): 6757-6774
URL https://www.wjgnet.com/1007-9327/full/v27/i40/6757.htm
DOI https://dx.doi.org/10.3748/wjg.v27.i40.6757
Full Article (PDF) WJG-27-6757.pdf
Full Article (Word) WJG-27-6757.docx